Abstract

BackgroundWith multiple strains of various pathogens being sequenced, it is necessary to develop high-throughput methods that can simultaneously process multiple bacterial or viral genomes to find common fingerprints as well as fingerprints that are unique to each individual genome. We present algorithmic enhancements to an existing single-genome pipeline that allows for efficient design of microarray probes common to groups of target genomes. The enhanced pipeline takes advantage of the similarities in the input genomes to narrow the search to short, nonredundant regions of the target genomes and, thereby, significantly reduces the computation time. The pipeline also computes a three-state hybridization matrix, which gives the expected hybridization of each probe with each target.ResultsDesign of microarray probes for eight pathogenic Burkholderia genomes shows that the multiple-genome pipeline is nearly four-times faster than the single-genome pipeline for this application. The probes designed for these eight genomes were experimentally tested with one non-target and three target genomes. Hybridization experiments show that less than 10% of the designed probes cross hybridize with non-targets. Also, more than 65% of the probes designed to identify all Burkholderia mallei and B. pseudomallei strains successfully hybridize with a B. pseudomallei strain not used for probe design.ConclusionThe savings in runtime suggest that the enhanced pipeline can be used to design fingerprints for tens or even hundreds of related genomes in a single run. Hybridization results with an unsequenced B. pseudomallei strain indicate that the designed probes might be useful in identifying unsequenced strains of B. mallei and B. pseudomallei.

Highlights

  • With multiple strains of various pathogens being sequenced, it is necessary to develop high-throughput methods that can simultaneously process multiple bacterial or viral genomes to find common fingerprints as well as fingerprints that are unique to each individual genome

  • BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496 tious Diseases and the U.S Department of Defense. Availability of these genomic sequences has opened up opportunities for the development of whole-genomebased diagnostic assays, such as DNA microarrays and polymerase chain reaction (PCR) assays, which offer more flexibility than traditional methods based on a single gene or selected regions of a target genome [1]

  • (page number not for citation purposes) http://www.biomedcentral.com/1471-2164/9/496 normalized hybridization intensity greater than RU with B. pseudomallei 238, and less than RL with the two strains of B. mallei and the strain of B. thailandensis tested. These results indicate that these group-specific probes can be used to identify B. pseudomallei 238, and possibly other unsequenced strains of B. mallei and B. pseudomallei

Read more

Summary

Introduction

With multiple strains of various pathogens being sequenced, it is necessary to develop high-throughput methods that can simultaneously process multiple bacterial or viral genomes to find common fingerprints as well as fingerprints that are unique to each individual genome. BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496 tious Diseases and the U.S Department of Defense Availability of these genomic sequences has opened up opportunities for the development of whole-genomebased diagnostic assays, such as DNA microarrays and polymerase chain reaction (PCR) assays, which offer more flexibility than traditional methods based on a single gene or selected regions of a target genome [1]. Kaderali and Schliep [6] presented one of the first methods for designing microarrays for pathogen identification Their approach is very similar to that of designing probes for gene expression analysis; they design a single probe for each target, with the probe being unique to the target with respect to all other input target sequences. This is clearly not adequate if the signatures are to be used to identify the pathogen from environmental/clinical samples containing any number of unanticipated non-target organisms

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.